CharlesWindonMD

Neurology • San Francisco, CA

Assistant Professor, UCSF Memory and Aging Center, UCSF Department of Neurology

Join to view full profile

Dr. Windon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Windon's full profile

Already have an account?

Office
675 Nelson Rising Lane
Suite 190
San Francisco, CA 94158
Phone+1 415-514-8507

Education & Training

University of California (San Francisco)Fellowship, Behavioral Neurology, 2019 - 2021
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2016 - 2019
Rutgers Robert Wood Johnson Medical SchoolClass of 2015
Princeton UniversityBA, Molecular Biology, 2006 - 2010

Certifications & Licensure

CA State Medical License 2019 - 2026
PA State Medical License 2015 - 2016
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

13 citations
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Hanna Cho, Nidhi S Mundada, Liana G Apostolova, Maria C Carrillo, Ranjani Shankar
Alzheimer's & Dementia. 2023-11-01
37 citations
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidenc...
Consuelo H Wilkins, Charles C Windon, Peggye Dilworth-Anderson, Justin Romanoff, Constantine Gatsonis
JAMA Neurology. 2022-10-03
9 citations
Association of remote mild traumatic brain injury with cortical amyloid burden in clinically normal older adults
Breton M Asken, William G. Mantyh, Renaud La Joie, Amelia Strom, Kaitlin B. Casaletto
Brain Imaging and Behavior. 2021-01-11

Journal Articles

Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or DementiaA Secondary Analysis of the Imaging Dementia–Evidence ...
Wilkins CH, Windon CC, Dilworth-Anderson P, et al., JAMA, 10/3/2022
Perils of Race-Based Norms in Cognitive Testing
Charles Windon, MD, JAMA Neurology

Press Mentions

Fewer Asian, Black, Hispanic Patients Eligible for Drugs That May Delay Alzheimer’s ProgressionOctober 14th, 2022
Neuroscientists to Reveal New Insights into Alzheimer’sOctober 20th, 2023